期刊文献+

microRNA-101和COX-2在结肠癌中的表达及其临床意义 被引量:19

Expressions of micro RNA-101 and cyclooxygenase-2 in colorectal cancer
下载PDF
导出
摘要 目的:检测结肠癌组织miR-101、COX-2的表达并探讨其临床意义。方法:收集结肠癌组织和癌旁组织标本32例,荧光定量PCR检测miR-101、COX-2 mRNA的表达,分析两者相关性及其与临床病理的关系。结果:与癌旁组织比较,结肠癌组织中miR-101表达相对降低(P<0.01),COX-2 mRNA表达相对增高(P<0.01),且两者表达呈负相关(r=-0.373 5,P<0.01)。结肠癌组织中COX-2的表达与肿瘤的分化程度无关(P>0.05);miR-101随肿瘤分化程度降低其表达也降低(P<0.05)。Dukes分期C^D期肠癌组织中COX-2表达量高于A^B期,miR-101的表达量低于A^B期,但差异均无统计学意义(P>0.05)。结论 :miR-101表达降低及COX-2过表达与结肠癌的发生有关,二者可以成为结肠癌的诊断标志物和潜在治疗靶点。 Objectives To investigate the expressions of miR-101 and COX-2 in colorectal cancer.Methods Thirty-twocolorectal cancer specimens and paired paracancer tissues were collected for assessment of miR-101 and COX-2 expressions by real-time quantitative PCR. Thecorrelation between miR-101 and COX-2, as well as their correlations with the pathologywere analyzed. Results The expression level of mi R-101 and COX-2 mRNA in the cancer tissues was significant difference between the cancer and para-cancer tissues(P 〈0. 01).Also, miR-101 expression was negatively correlated with COX-2 mRNA expression(r =-0.373 5, P〈 0.01).Furthermore,miR-101 expression was significantlydecreased along with the deterioration of tumor differentiation grade(P〈 0.05). Compared with which in Dukes A ~ B stage, COX-2 expression was overexpressed and mi R-101 was down-regulatedin colorectal cancer tissue in Dukes C ~ Dstage, butnosignificant difference was found( P 〉0.05). Conclusion Down-regulated miR-101 expression andparallel COX-2 overexpression hasbeen linked to colorectal cancer. miR-101 and COX-2might be thepotentialdiagnostic markers and therapeutic targets.
出处 《实用医学杂志》 CAS 北大核心 2016年第5期739-742,共4页 The Journal of Practical Medicine
基金 国家自然科学基金资助项目(编号:81201662)
关键词 结肠癌 miRNA-101 环氧合酶2 Colorectal Cancer miRNA-101 Cyclooxygenase 2
  • 相关文献

参考文献18

  • 1张玥,石菊芳,黄慧瑶,任建松,李霓,代敏.中国人群结直肠癌疾病负担分析[J].中华流行病学杂志,2015,36(7):709-714. 被引量:190
  • 2KOWALEWSKI M P, SCHULER G, TAUBERT A, et al. Expression of cyclooxygenase 1 and 2 in the canine corpus luteum during diestrus [ J ]. Theriogenology, 2006,66 (6) : 1423-1430.
  • 3WANG D, DUBOIS R N. The role of COX-2 in intestinal in- flammation and colorectal cancer [J]. Oncogene, 2010,29(6): 781-788.
  • 4BU Q, FANG Y, CAO Y, et al. Enforced expression of miR- 101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway [J]. Mol Med Rep, 2014,10(4) : 2203-2209.
  • 5ALEXANIAN A, MILLER B, CHESNIK M, et al. Post-translational regulation of COX2 activity by FYN in prostate cancer ceils [J]. Oncotarget, 2014,5(12) :4232-4243.
  • 6CHIKMAN B, VASYANOVICH S, LAVY R, et al. COX2 expression in high-grade breast cancer: evidence for prognostic sig- nificance in the subset of triple-negative breast cancer patients [J]. Med Oncol, 2014,31(6): 989.
  • 7AGGARWAL A, AL-ROHIL R N, BATRA A, et al. Expression of integrin alpha3betal and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer [J]. BMC Cancer, 2014, 14( 1 ) :459-471.
  • 8TYAGI A, AGARWAL C, DWYER-NIELD LD, et al. Silibinin modulates TNF-alpha and IFN-gamma mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung ep- ithelial LM2 cells [J]. Mol Carcinog, 2012,51 (10) : 832-842.
  • 9李祖国,刘腾飞,谢卫兵,周军,余力,丁彦青.环氧化酶2基因异常表达与大肠癌转移的关系[J].南方医科大学学报,2006,26(10):1408-1411. 被引量:9
  • 10WONG J, OBERMAJER N, EDWARDS R, et al. Activation of the COX2/PGE2 axis by immune effector cells promotes the self- limiting nature of type-1 immunity in cancer tissues (VAC3P. 939) [J]. The Journal of Immunology, 2014, 192 (1 Supple- ment) :71-73.

二级参考文献45

  • 1李连弟,陈育德.中国恶性肿瘤死亡调查研究(1990-1992)[M].北京:人民卫生出版社.2008.
  • 2陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 3Higashi Y,Kanekura T,Kanzaki T.Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells:evidence for growth suppression by inhibiting COX-2 expression[J].Int J Cancer,2000,86(5):667-71.
  • 4Gotte K,Riedel F,Coy JF,et al.Salivary gland carcinosarcoma:immunohistochemical,molecular genetic and electron microscopic findings[J].Oral Oncol,2000,36(4):360-4.
  • 5Bae SH,Jung ES,Park YM,et al.Expression of cycloox-ygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor,NS-398[J].Clin Cancer Res,2001,7(5):1410-8.
  • 6Fux R,Schwab M,Thon KP,et al.Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival[J].Clin Cancer Res,2005,11(13):4754-60.
  • 7Thun M,Namboodiri M,Health C Jr.Aspirin use and reduced risk of fatal colon cancer[J].N Engl J Med 1991,325(23):1593-6.
  • 8Eberhart CE,Coffey,RJ,Radhika A,et al.Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas[J].Gastroenterology,1994,107(4):1183-8.
  • 9Subbamaraiah K T N,Ramonetti JT,et al.Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells[J].Cancer Res,1996,56:4424-9.
  • 10Williams CS,Luongo C,Radhika A,et al.Elevated cycloxxygenase-2 levels in Min mouse adenoma[J].Gastroenterology.Gastroenterology,1996,111(4):1134-40.

共引文献206

同被引文献164

引证文献19

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部